SCHEMBL25392645

SCHEMBL25392645

Cc1cccc(N2CCN(C(C)(C)C(=O)NC3CC3)CC2)c1C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 1/20 0.60
▸ KDM4E B2RXH2 3/20 0.54
▸ ALDH1A1 P00352 4/20 0.52
▸ MAPT P10636 4/20 0.51
▸ TSHR P16473 4/20 0.51
▸ MEN1 O00255 3/20 0.51
▸ KMT2A Q03164 3/20 0.51
▸ NPSR1 Q6W5P4 3/20 0.51
▸ LMNA P02545 6/20 0.49
▸ ALOX15 P16050 2/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ SIGMAR1 Q99720 1/20 0.44
▸ GLA P06280 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ REV1 Q9UBZ9 1/20 0.44
▸ ADRB1 P08588 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26238508 0.94 RAB9A (0.69) RAB9AKDM4EALDH1A1MAPTTSHR
SCHEMBL26238509 0.82 TSHR (0.60) RAB9AKDM4EALDH1A1MAPTTSHR
SCHEMBL26238626 0.81 HSD11B1 (0.45) RAB9AALDH1A1MEN1KMT2ANPSR1
SCHEMBL26238502 0.81 ALDH1A1 (0.55) RAB9AKDM4EALDH1A1MAPTTSHR
SCHEMBL26238510 0.80 TSHR (0.67) RAB9AKDM4EALDH1A1MAPTTSHR
SCHEMBL26238518 0.80 ALDH1A1 (0.52) RAB9AKDM4EALDH1A1MAPTTSHR
SCHEMBL26238620 0.80 ALDH1A1 (0.52) KDM4EALDH1A1MAPTTSHRMEN1
SCHEMBL25390175 0.80 ALDH1A1 (0.61) RAB9AKDM4EALDH1A1MAPTTSHR
SCHEMBL26238519 0.79 MAPT (0.53) RAB9AKDM4EALDH1A1MAPTTSHR
SCHEMBL26238503 0.79 ALDH1A1 (0.53) KDM4EALDH1A1MAPTTSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250280861-A1 SWEETENER COMPOSITIONS FIRMENICH INCORPORATED (US) 2025-09-11 — — US disclosed
EP-4472947-A1 SWEETENER COMPOSITIONS Firmenich Incorporated (US) 2024-12-11 — — EP disclosed
WO-2023172415-A1 SWEETENER COMPOSITIONS FIRMENICH INCORPORATED (US) 2023-09-14 — — WO disclosed
WO-2023172415-A1 SWEETENER COMPOSITIONS FIRMENICH INCORPORATED (US) 2023-09-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250280861-A1 SWEETENER COMPOSITIONS GPR119, TAS2R50, TAS2R30 RAB9A 2089/4885KDM4E 4072/4885ALDH1A1 1279/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback